These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 3100601)
21. New directions in antiarrhythmic drug therapy. Somberg JC Am J Cardiol; 1984 Aug; 54(4):8B-17B. PubMed ID: 6147082 [TBL] [Abstract][Full Text] [Related]
22. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide]. Halawa B Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685 [TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacology of antiarrhythmic agents. Kelliher GJ; Kowey P; Engel T; Wetstein L Cardiovasc Clin; 1985; 16(1):287-305. PubMed ID: 2874883 [No Abstract] [Full Text] [Related]
25. Clinical pharmacokinetics of the newer antiarrhythmic agents. Gillis AM; Kates RE Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721 [TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II. Singh BN; Cho YW; Kuemmerle HP Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721 [No Abstract] [Full Text] [Related]
27. New drugs for treatment of ventricular arrhythmias. Heger JJ; Prystowsky EN; Zipes DP Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255 [TBL] [Abstract][Full Text] [Related]
30. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide. Pottage A Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279 [TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents. Roden DM Postgrad Med; 1985 Sep; 78(4):28-37. PubMed ID: 2412217 [No Abstract] [Full Text] [Related]
32. Antiarrhythmic drug therapy. Recent advances and current status. Somberg J Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841 [TBL] [Abstract][Full Text] [Related]
33. Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs. Nademanee K; Singh BN JAMA; 1982 Jan; 247(2):217-22. PubMed ID: 6796709 [No Abstract] [Full Text] [Related]
34. Metabolites of antiarrhythmic drugs: are they clinically important? Kates RE Ration Drug Ther; 1986 May; 20(5):1-5. PubMed ID: 3097754 [No Abstract] [Full Text] [Related]
39. Tocainide--an alternative to mexiletine. Drug Ther Bull; 1982 Jul; 20(14):55-6. PubMed ID: 6814882 [No Abstract] [Full Text] [Related]
40. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole]. Wagner WL; Manz M; Lüderitz B Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]